Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Yachmetz Philip K
Relationship:   Co-President and CBO
City:   Wyckoff
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   98,241    

Indirect Shares

   200      
Direct Value   $31,554    

Indirect Value

   $820      
Total Shares   98,441      
Total Value   $32,374      


Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0 Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progenics Pharmaceuticals Inc PGNX VP, General Counsel 2004-05-03 7,696 2004-05-03 200    Premium*  
            Savient Pharmaceuticals Inc SVNTQ Co-President and CBO 2013-10-15 90,545 2004-06-04 0    Premium*  
* Premium Members only  

Records found :    53         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGNX Progenics Pharmaceuticals... VP, General Counsel and Secy   •       –      –    2004-04-01 4 A $8.30 $813 D/D 98 7,732 -
PGNX Progenics Pharmaceuticals... VP, Gen Counsel & Secretary   •       –      –    2004-01-05 4 A $8.01 $1,226 D/D 153 7,634 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2013-01-14 4 AS $1.14 $1,463 D/D (1,283) 334,201 0 -
PGNX Progenics Pharmaceuticals... VP, Gen Counsel and Secretary   •       –      –    2003-07-01 4 A $9.84 $14,937 D/D 1,518 5,695 -
PGNX Progenics Pharmaceuticals... VP,General Counsel/Secretary   •       –      –    2003-10-01 4 A $9.10 $16,253 D/D 1,786 7,481 -
PGNX Progenics Pharmaceuticals... VP, General Counsel   •       –      –    2004-05-03 4 OE $12.29 $24,580 D/D 2,000 0 -
PGNX Progenics Pharmaceuticals... VP, General Counsel   •       –      –    2004-05-03 4 AS $19.15 $38,502 D/D (2,000) 7,696 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-02-15 4 AS $20.01 $47,233 D/D (2,361) 140,726 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-02-20 4 AS $20.01 $49,113 D/D (2,455) 138,271 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2007-02-15 4 AS $14.44 $44,045 D/D (3,051) 109,007 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2011-02-14 4 AS $9.88 $31,724 D/D (3,210) 182,024 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2012-02-14 4 AS $2.02 $7,151 D/D (3,540) 235,484 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2009-09-14 4 S $15.75 $59,063 D/D (3,750) 182,073 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2009-09-15 4 S $16.25 $60,938 D/D (3,750) 178,323 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-04-14 4 AS $19.00 $71,919 D/D (3,785) 145,811 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2007-04-12 4 AS $12.06 $45,904 D/D (3,805) 150,861 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2006-04-12 4 AS $5.87 $29,297 D/D (4,992) 67,058 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-02 4 OE $2.42 $12,100 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-02 4 S $23.47 $117,331 D/D (5,000) 143,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-03 4 S $24.26 $121,286 D/D (5,000) 143,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-03 4 OE $2.42 $13,450 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-04 4 OE $2.78 $13,900 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-04 4 S $23.27 $116,331 D/D (5,000) 143,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-07 4 OE $2.42 $13,450 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-07 4 S $23.02 $115,106 D/D (5,000) 143,087 0 -
  53  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us